Company intelligence / Profile preview

Hacarus

Ownership: Private
Employees: ~34
Development stage: Commercial

Overview

Hacarus provides proprietary sparse modeling-based artificial intelligence solutions that deliver explainable results from small data sets. In healthcare, its "HACARUS MD" platform supports professionals with medical image and vital data analysis. The company’s technology is also widely used for visual inspection automation in manufacturing, construction, infrastructure, and semiconductor sectors. No clinical trial results are reported as the company does not develop therapeutics directly.

Therapeutic areas: Other
Modalities: DeviceSoftware
Industry: Digital Health Medical Devices

Partnerships

Mitsubishi ElectricDaikin IndustriesOsaka GasMiyako Capital (Kyoto University)BMW Startup Garage

Beyond the preview

Go deeper on Hacarus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hacarus.

Explore the full profile